Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Mechanisms and Clinical Applications of Buyang Huanwu Decoction in the Treatment of Ischemic Stroke: A Review. | Int J Gen Med | 2026 | 41810314 | PubTator, text mining | PubMed |
| Anjiang formula inhibits PVN microglial activation and lowers blood pressure by targeting RhoA/ROCK2 pathway: a retrospective clinical and experimental study. | Front Pharmacol | 2026 | 41800080 | PubTator, text mining | PubMed |
| Host modulation therapy in periodontitis: from established therapies to emerging technologies. | Front Immunol | 2026 | 41798927 | PubTator, text mining | PubMed |
| Mitochondrial-targeted therapy for osteoarthritis: Challenges and opportunities from basic research to clinical translation. | Front Immunol | 2026 | 41798918 | PubTator, text mining | PubMed |
| Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement. | Bone Marrow Transplant | 2026 | 41795054 | PubTator, text mining | PubMed |
| Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis. | Cell | 2026 | 41794026 | PubTator, text mining | PubMed |
| ROCK signaling at the crossroads of redox stress, mitochondrial dynamics, and metabolic disease. | Redox Biol | 2026 | 41791289 | PubTator, text mining | PubMed |
| Circular RNAs in sepsis-induced acute lung injury: emerging mechanisms and therapeutic potential. | Front Immunol | 2026 | 41789098 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| Dietary carboxymethylcellulose metabolite promotes heart allograft rejection through induction of proinflammatory macrophages via lysophosphatidic acid. | Am J Transplant | 2026 | 41780895 | PubTator, text mining | PubMed |
| Coronary Artery Spasm in Patients with Type 2 Diabetes Mellitus. | Life (Basel) | 2026 | 41752989 | PubTator, text mining | PubMed |
| Selective Inhibitor of Protein Kinase PKN3 Generated by Conjugation of a Structurally Optimized Bumped N-(2-Aminoethyl)-8-anilinoisoquinoline-5-sulfonamide (H-9) with d-Arginine-Rich Chain. | Molecules | 2026 | 41752364 | PubTator, text mining | PubMed |
| Maintaining Genome Integrity: Actin Polymerization Stabilizes Chromatin Bridges in Cytokinesis. | Int J Mol Sci | 2026 | 41752129 | PubTator, text mining | PubMed |
| Design and Fabrication of Biomimetic Gradient Bone Tissue Engineering Scaffolds: Evolution from Single-Gradient to Multi-Gradient. | Gels | 2026 | 41745003 | PubTator, text mining | PubMed |
| Extracellular vesicles in rheumatoid arthritis: emerging roles in progression, diagnosis, and therapeutic development. | Front Immunol | 2026 | 41743711 | PubTator, text mining | PubMed |
| Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation. | Life Sci Alliance | 2026 | 41735013 | PubTator, text mining | PubMed |
| Looking at endometriosis-diagnosis and disease mechanisms through a mechanical lens. | Front Med (Lausanne) | 2026 | 41728603 | PubTator, text mining | PubMed |
| HSP90B1 facilitates glioma radiotherapy resistance by regulating RhoC ubiquitin‒proteasome degradation. | Genes Dis | 2026 | 41716636 | PubTator, text mining | PubMed |
| Real-world outcomes in refractory chronic graft-versus-host disease: the Italian multicenter experience with belumosudil. | Haematologica | 2026 | 41709738 | PubTator, text mining | PubMed |
| Regulation of platelet contractility by agonists present across a thrombus. | Blood Adv | 2026 | 41701975 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=4